← Back to patent-cliff list
CAS 369-34-6
1,2-difluoro-4-nitrobenzene
Codes: LINE-001, SUTEZ-001, DELPA-001
Application context (from source-drug indications)
非复杂性皮肤和皮肤结构感染LinezolidPneumoniaLinezolidComplicated skin and skin structure infectionLinezolidBacteraemiaLinezolidBacterial infectionLinezolidHealthcare-associated pneumoniaLinezolidMycobacterium tuberculosis infectionSutezolidPulmonary tuberculosisSutezolidNon-tuberculous mycobacterial infectionDelpazolidPulmonary tuberculosisDelpazolidMycobacterium tuberculosis infectionDelpazolidStaphylococcal infectionDelpazolid
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Linezolid | Tier B — Position early | - |
| Sutezolid | Tier C — Watch / trade | - |
| Delpazolid | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,2-difluoro-4-nitrobenzene→morpholine→4-(2-fluoro-4-nitrophenyl)morpholine→3-fluoro-4-morpholinoaniline→benzyl (3-fluoro-4-morpholinophenyl)carbamatebenzyl (3-fluoro-4-morpholinophenyl)carbamate→(R)-oxiran-2-ylmethyl butyrate→(R)-3-(3-fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one→(R)-(3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate→(R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
1,2-difluoro-4-nitrobenzene→morpholine→4-(2-fluoro-4-nitrophenyl)morpholine→3-fluoro-4-morpholinoaniline→(R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one→4-(2-fluoro-4-isocyanatophenyl)morpholine→(R)-2-(chloromethyl)oxirane→(R)-5-(chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
1,2-difluoro-4-nitrobenzene→thiomorpholine→4-(2-fluoro-4-nitrophenyl)thiomorpholine→benzyl (3-fluoro-4-thiomorpholinophenyl)carbamate→(R)-oxiran-2-ylmethyl butyrate→(R)-3-(3-fluoro-4-thiomorpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one→(R)-(3-(3-fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl 4-methylbenzenesulfonate→(R)-5-(azidomethyl)-3-(3-fluoro-4-thiomorpholinophenyl)oxazolidin-2-one→(S)-N-((3-(3-fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
1,2-difluoro-4-nitrobenzene→2-((2-fluoro-4-nitrophenyl)amino)ethan-1-ol→tert-butyl (2-((tert-butyldimethylsilyl)oxy)ethyl)(2-fluoro-4-nitrophenyl)carbamate→tert-butyl (4-amino-2-fluorophenyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)carbamate→tert-butyl (4-(((benzyloxy)carbonyl)amino)-2-fluorophenyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)carbamate→(R)-oxiran-2-ylmethyl pivalate→tert-butyl (R)-(2-((tert-butyldimethylsilyl)oxy)ethyl)(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)carbamate→(R)-(3-(4-((tert-butoxycarbonyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)amino)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl benzoate→(R)-(3-(3-fluoro-4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl benzoate→(R)-(3-(3-fluoro-4-((2-((methylsulfonyl)oxy)ethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl benzoate→(R)-(3-(3-fluoro-4-((2-hydrazineylethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl benzoate→(R)-4-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)-5,6-dihydro-1,2,4-triazine-1(4H)-carbaldehyde→(R)-3-(4-(5,6-dihydro-1,2,4-triazin-4(1H)-yl)-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one→(R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
1,2-difluoro-4-nitrobenzene→2-((2-fluoro-4-nitrophenyl)amino)ethan-1-ol→(R)-oxiran-2-ylmethyl pivalate→1-(2-fluoro-4-nitrophenyl)aziridine→2-fluoro-N-(2-(1-methylhydrazineyl)ethyl)-4-nitroaniline→4-(2-fluoro-4-nitrophenyl)-1-methyl-1,4,5,6-tetrahydro-1,2,4-triazine→3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)aniline→ethyl (3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)carbamate→(R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.